Active Ingredient: Mannitol
Promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible oliguric renal failure becomes established.
For this indication, competent medicine agencies globally authorize below treatments:
Intravenous
0.5 - 1.5 g per kg of body weight
From 0.5 To 1.5 g per kg of body weight once every day
In renal insufficiency, the test dose should be 200 mg mannitol/kg over 3-5 minutes. The treatment dose ranges from 0.5 to 1.5 g/kg. This dose may be repeated once or twice, after an interval of 4 to 8 hours, if necessary.
This hypertonic solution should be administered via a large peripheral or, preferably, a central vein. Rapid infusion in peripheral veins may be harmful.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
